Prospective, multicenter registry of PCI to assess efficay and safety of the PEB, second generation DIORTM (EuroCor, Germany), for the treatment of de novo ostial bifurcated lesions (001 of Medina classif)

METHODS

Inclusion Criteria

• 001 de novo Bifurcated lesion (ostium SB ≥ 2.0mm)
• Clinical evidence of myocardial ischemia related to the TL
• Target lesion ≥ 50%

Exclusion criteria:

• Cardiogenic shock
• Patients survival to less than one year
• Angiographic:
  • LM bifurcation lesion: Ostial LAD and LCx lesions
  • Lesion length > 25 mm
  • Target vessel reference diameter < 2mm
  • Severe angiographic calcification

CONCLUSION

• Y-angle (53o) was the most frequent and lesions were placed in “diferent” small vessel in which acute recoil seems to be the most important limiting factor for DEB angioplasty
• Importance of plaque preparation with cutting balloon pre-dilatation needs to be determined